Who owns ALKS
378 institutions reported holding ALKS for 2026Q1, together 106% of the company, more than the 358 a quarter earlier.
378
Institutions reporting a position · as of 2026Q1 · up from 358 the quarter before
- Shares held by institutions
- 175.5M
Shares held by institutions · 106% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $6.18B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 43%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 66
- Positions exited
- 51
- Added to
- 107
- Reduced
- 141
- Top 10 holdersof the company
- 58%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 378 | 175.5M | $6.18B |
| 2025Q4 | 358 | 180.3M | $5.05B |
| 2025Q3 | 351 | 169.5M | $5.08B |
| 2025Q2 | 345 | 169.1M | $4.84B |
| 2025Q1 | 363 | 172.1M | $5.68B |
| 2024Q4 | 339 | 167.3M | $4.81B |
| 2024Q3 | 334 | 178.8M | $5.00B |
| 2024Q2 | 320 | 179.4M | $4.32B |
| 2024Q1 | 333 | 176.1M | $4.77B |
| 2023Q4 | 298 | 175.4M | $4.87B |
| 2023Q3 | 302 | 163.3M | $4.57B |
| 2023Q2 | 287 | 160.6M | $5.03B |
| 2023Q1 | 263 | 161.6M | $4.55B |
| 2022Q4 | 275 | 162.2M | $4.24B |
| 2022Q3 | 271 | 159.7M | $3.57B |
| 2022Q2 | 271 | 156.6M | $4.66B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Inc. | 28.3M | 17% | $1.00B |
| VANGUARD GROUP INC | 18.3M | 11% | $649M |
| BAKER BROS. ADVISORS LP | 10.0M | 6.0% | $354M |
| STATE STREET CORP | 9.5M | 5.7% | $335M |
| RENAISSANCE TECHNOLOGIES LLC | 6.2M | 3.7% | $218M |
| AMERICAN CENTURY COMPANIES INC | 6.1M | 3.7% | $215M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.7M | 2.8% | $165M |
| DIMENSIONAL FUND ADVISORS LP | 4.5M | 2.7% | $160M |
| Commodore Capital LP | 4.2M | 2.5% | $149M |
| GEODE CAPITAL MANAGEMENT LLC | 4.2M | 2.5% | $148M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #21 of 28 by Smart Score